The global animal drug compounding market has demonstrated robust expansion, valued at US$ 1.1 Billion in 2021, and is projected to achieve a notable compound annual growth rate (CAGR) of 7.4% from 2022 to 2031. According to recent market analysis, the industry is anticipated to surpass US$ 2.4 Billion by the end of the forecast period. This upward trajectory is primarily fueled by a surge in...
